spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

4th Annual Genome Editing Congress

Oxford Global Events - Gene Editing

8-9 November 2018
London, UK

Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.

Our Genome Editing Congress will feature over 20 presentations and case studies focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies. 

World renowned experts will give over 20 presentations across 2 interactive streams, including;

·         Genome Editing Techniques and Technologies

·         Therapeutic Applications of Genome Editing

View the Agenda here>> https://bit.ly/2s1kWe7

This event will be co-located with the highly established 10th Annual Next Generation Sequencing and Clinical Diagnostics Congress, 6th Annual Single Cell Analysis Congress and the Synthetic Biology Congress.

Free Pre-Congress Live Webinars

Approaching CRISPR Intellectual Property Issues
Hosted by Catherine Coombes, Patent Director, HGF Limited

Register for free today: https://bit.ly/2J2gR0s

Design, Deliver & Detect: Considerations For Optimized In Vitro And Ex Vivo CRISPR Applications.
Hosted by Eric Paul Bennett, Associate Professor, University of Copenhagen

Register for free today: https://bit.ly/2IUsHxL

Can’t make the date? Register today and the recording of the webinar will be sent to you afterwards.

For further information, prices & group discounts please contact d.dalby@oxfordglobal.co.uk

 

phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2tHrM9q
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

White Papers

Clinical Trial Labelling – More Than Just Labels

Faubel & Co. Nachfolger GmbH

Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >>


News and Press Releases

3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

[Noáin, May 27, 2019] 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement